These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 3789753)

  • 1. [Studies on the enhancement of anti-tumor activity in patients with cervical cancer by local administration of OK-432].
    Yamada Y; Yamamoto K; Wakita K; Shiraki S; Noda K
    Gan To Kagaku Ryoho; 1986 Dec; 13(12):3427-31. PubMed ID: 3789753
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Modulation of NK activity in regional lymph nodes by preoperative immunotherapy with OK-432 in patients with cancer of the oral cavity.
    Vinzenz K; Matejka M; Watzek G; Porteder H; Neuhold N; Micksche M
    Cancer Detect Prev Suppl; 1987; 1():463-75. PubMed ID: 3480060
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Study on enhancement of antitumor immunity in cervical cancer--with reference to administration of immunopotentiators].
    Wakida K
    Nihon Sanka Fujinka Gakkai Zasshi; 1987 Mar; 39(3):432-8. PubMed ID: 3559328
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Effects of preoperative local administration of BRM on cellular immunity and prognosis of patients with esophageal cancer].
    Tanaka Y; Miyama T; Suda Y; Fujita K; Takubo K
    Gan To Kagaku Ryoho; 1991 Aug; 18(11):1780-3. PubMed ID: 1877817
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Endoscopic preoperative intralesional injection of OK-432 in early gastric cancer].
    Yamane T; Sagara Y; Suzuki G; Kasuga M; Sakita M; Fujita Y; Majima S
    Gan To Kagaku Ryoho; 1984 Apr; 11(4):930-4. PubMed ID: 6721507
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [A case of advanced gastric cancer responsive to intratumoral OK-432 injection].
    Sakai Y; Maeda M; Koyama W; Totsuka S; Sakamoto S; Kanayama M
    Gan To Kagaku Ryoho; 1988 Jun; 15(6):1978-80. PubMed ID: 3382244
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Clinical study on the effect of intratumoral administration of OK-432 on breast cancer--anti-tumor immune response at the site of local injection].
    Hosokawa T
    Nihon Geka Gakkai Zasshi; 1991 May; 92(5):577-86. PubMed ID: 1831533
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Augmentation of cytotoxicity of regional lymph node lymphocytes of gastric cancer after intratumoral injection of OK-432].
    Kobayashi G
    Nihon Geka Gakkai Zasshi; 1990 Jan; 91(1):68-76. PubMed ID: 2314383
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [A double blind study to evaluate the optimal dose and its frequency for oral administration of OK-432 (picibanil) by immunological parameters (the 2nd report)].
    Shiraishi T; Nio Y; Imai S; Tsubono M; Morimoto H; Tseng CC; Tobe T; Tanaka T; Kitamura O; Sakanashi S
    Nihon Gan Chiryo Gakkai Shi; 1990 May; 25(5):997-1012. PubMed ID: 2202770
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Endoscopic administration of OK-432 in gastric cancer].
    Inbe A; Sumii K; Haruma K; Uemura N; Tari A; Yoshihara M; Tokutomi T; Inaba Y; Sekito M; Ogoshi H
    Gan To Kagaku Ryoho; 1986 Mar; 13(3 Pt 1):514-9. PubMed ID: 3954375
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Monoclonal antibody to the streptococcal preparation OK-432: tissue OK-432 localization and analysis of interaction between OK-432 and macrophages or NK cells in human salivary adenocarcinoma-bearing nude mice given OK-432.
    Sato M; Kaji R; Urata M; Yoshida H; Yanagawa T; Miyamoto K; Azuma M; Furumoto N; Saito M
    J Biol Response Mod; 1988 Apr; 7(2):212-28. PubMed ID: 3361352
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Effective mechanisms of BRM, with special reference to induction of autologous tumor cell-killing (ATK) activity by OK-432].
    Hoshino T; Uchida A
    Gan To Kagaku Ryoho; 1986 Apr; 13(4 Pt 2):1277-84. PubMed ID: 3488024
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [A double blind study of the evaluation of the optimal dose and its frequency in oral administration of OK-432 (Picibanil) by immunological parameters (the 1st report)].
    Shiraishi T; Nio Y; Imai S; Tsubono M; Morimoto H; Tseng CC; Tobe T; Tanaka T; Kitamura O; Sakanashi S
    Nihon Gan Chiryo Gakkai Shi; 1990 Apr; 25(4):799-811. PubMed ID: 2196311
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Oral administration of OK-432 (picibanil). (8th report) clinical application: its immunomodulatory effects on the patients with gastrointestinal cancers].
    Nio Y; Ohgaki K; Tsuchitani T; Imai S; Shiraishi T; Tsubono M; Morimoto H; Tseng CC; Tobe T
    Nihon Gan Chiryo Gakkai Shi; 1989 Aug; 24(8):1607-15. PubMed ID: 2809385
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunohistochemical studies on local antitumor effects of streptococcal immunopotentiator, OK-432, in human solid malignant tumors.
    Sugenoya A; Usuda N; Adachi W; Kaneko G; Nagata T; Iida F
    Arch Pathol Lab Med; 1988 May; 112(5):545-9. PubMed ID: 3282486
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Analysis of immunological response of regional lymph node lymphocytes from patients with gastric cancer after endoscopic local injection of biological response modifier (BRM)].
    Obi Y
    Nihon Geka Gakkai Zasshi; 1991 Mar; 92(3):293-302. PubMed ID: 2051981
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Local immunotherapy for cancer].
    Hattori T; Niimoto M; Toge T; Hamamoto S; Seto Y; Kameda A; Tomoda S
    Nihon Geka Gakkai Zasshi; 1984 Sep; 85(9):1157-61. PubMed ID: 6503978
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Effect of selective intra-arterial infusion of OK-432 against renal cell cancers].
    Fujioka T; Tanji S; Koike H; Kumagai K; Suzuki K; Aoki H; Banya Y; Kubo T; Ohhori T
    Hinyokika Kiyo; 1987 Jun; 33(6):832-7. PubMed ID: 3673835
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Experimental study of oral administration of streptococcal preparation "OK-432". The third report: its enhancing effects on natural killer activity and lymphoproliferative response to mitogens of mouse mesenteric lymph node].
    Nio Y; Inamoto T; Kan N; Hori T; Nakayama N; Yamasaki N; Hikasa Y; Tsuchitani T; Ban S; Nagai T
    Nihon Gan Chiryo Gakkai Shi; 1984 May; 19(4):803-10. PubMed ID: 6491430
    [No Abstract]   [Full Text] [Related]  

  • 20. [Metastatic behavior of footpad-inoculated tumors in mice and the impact of OK-432 per os administration].
    Nakajima Y; Akimoto M; Kimura M; Iwasaki H; Matano S; Hirakawa H; Mori S
    Gan To Kagaku Ryoho; 1987 May; 14(5 Pt 1):1229-33. PubMed ID: 3579323
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.